Root cause analysis keeps landing on the same categories: software, components, design. But which one actually needs CAPA resources first? You're reviewing this week's nonconformance trends, trying to

Here's what's happening right now: 26,202 new regulatory signals hit the system today. Among the high-priority FDA Adverse Event Reports, we see multiple malfunctions in insulin pumps (Tandem Diabetes Care's t:slim X2 with Control-IQ Technology) and video systems (Shirakawa Olympus's Visera Video System Center and Camera Head). The Olympus investigation specifically noted "a root cause could not be identified" with the most probable cause traced to "component failure."

For CAPA prioritization under 21 CFR 820.90 and ISO 13485 8.5.2, this data suggests component failures in active implantable and surgical visualization devices should be elevated in your risk assessment. When you see "investigation on-going" in manufacturer narratives alongside patient-critical devices, it indicates potential systemic issues that may require immediate supplier quality reviews and enhanced incoming inspection protocols.

We analyzed this across 548,000+ regulatory records and found that component-related malfunctions in software-dependent medical devices consistently correlate with extended investigation timelines and subsequent regulatory actions when not addressed proactively in the QMSR framework.

See how your specific product codes compare to these emerging patterns at truemeddevice.com.